CorporateInformation.com
 
Company Search:
Advanced Search
 
Featured Products and Services
 

Wright Current Income Fund - 25th anniversary

 
 
 
 
 
 
BML, Inc. Company Snapshot
BML, Inc. operates in the Medical laboratories sector. In addition to historical fundamental analyses, the complete report available to purchase compares BML with three other pharmaceutical manufacturers in Asia: Falco Sd Holdings Company Limited (2013 sales of 62.76 billion Japanese Yen [US$616.28 million] of which 47% was Medical Test), Zhejiang DiAn Diagnostics Co Ltd of China (1.02 billion Chinese Renmimbi [US$163.22 million] ), and Medical & Biological Laboratories Company Limited (6.92 billion Japanese Yen [US$68.00 million] of which 100% was Reagent business).

Sales Analysis. BML reported sales of ¥94.61 billion (US$929.05 million) for the fiscal year ending March of 2013. This represents an increase of 2.6% versus 2012, when the company's sales were ¥92.20 billion. Sales at BML have increased during each of the previous five years (and since 2008, sales have increased a total of 30%). Sales of Related Businesses saw an increase that was more than double the company's growth rate: sales were up 8.2% in 2013, from ¥219.00 million to ¥237.00 million. Not all segments of BML experienced an increase in sales in 2013: sales of Medical Information fell 0.8% to ¥3.23 billion. (However, this segment's sales were only a very small portion of the company's overall sales).
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
BML, Inc.
  Stock Performance Chart for BML, Inc.
 
  Stock Data: Recent Stock Performance:
  Current Price (4/11/2014): 3,770.00
(Figures in Japanese Yen)
1 Week -3.6%   13 Weeks 11.4%  
4 Weeks 3.4%   52 Weeks 47.1%  
 
BML, Inc. Key Data:
  Ticker: 4694 Country: Japan
  Exchanges: TYO Major Industry: Health Care Equipment & Services
    Sub Industry: Medical Laboratories
  2013 Sales 94,608,000,000
(Year Ending Jan 2014).
Employees: 3,866
  Currency: Japanese Yen Market Cap: 80,067,836,810
  Fiscal Yr Ends: March Shares Outstanding: 21,238,153
  Share Type: Common Closely Held Shares: 12,692,400
 
 
Featured Products and Services
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.